At the time her salary was negotiated with the board the liquidity landscape for biotechs was different. If history was different, and had the market bid up the price of CHM, they could have done easy raises in a rising share price environment and had decent justification for paying one individual that much money, and she might have still been CEO today.
However the market chose to bid CHM DOWN. To the point of suffocation. So looking at where the company is today, the market has decided the answer is clearly YES, she is too expensive in this point of time. The market has also played a big part in the FUTURE history of CHM, as the intense backroom changes in leadership overlapping with frontline drugs hitting arms, this could instantly become a hot space.
This company is like a person living the highs and lows of a rock n roll superstar!
- Forums
- ASX - By Stock
- Ann: Notice of Extraordinary General Meeting/Proxy Form
At the time her salary was negotiated with the board the...
-
- There are more pages in this discussion • 231 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
|
|||||
Last
1.7¢ |
Change
0.001(6.25%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
1.7¢ | 1.9¢ | 1.7¢ | $45.06K | 2.512M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 62187 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 62187 | 0.017 |
17 | 2833886 | 0.016 |
19 | 2586784 | 0.015 |
3 | 708475 | 0.014 |
2 | 222223 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 1896071 | 5 |
0.020 | 1523093 | 7 |
0.021 | 290857 | 3 |
0.022 | 600000 | 2 |
0.023 | 150000 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online